What top creators are saying about Cel-Sci Corporation(CELC)
Biotechnology company with a PI3K drug, Jedatolisib.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Cel-Sci Corporation in the last 30 days yet.
Top creators covering Cel-Sci Corporation (CELC)
The 1 sources with the most insights about Cel-Sci Corporation on Kazuha.
Latest insights about Cel-Sci Corporation (CELC)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, July 28, 2025
The company reported 'extremely potent and impressive' trial data. The speaker believes it is a 'buy' even after a large price increase, seeing potential for its drug to generate $1 billion in revenue.
Monday, July 28, 2025
The company reported 'extremely potent and impressive' trial data. The speaker believes it is a 'buy' even after a large price increase, seeing potential for its drug to generate $1 billion in revenue.
Discussed alongside Cel-Sci Corporation (CELC)
Other assets that creators frequently mention in the same content as Cel-Sci Corporation.
Frequently asked
Which podcasters and creators cover Cel-Sci Corporation (CELC) the most?
The most active sources covering Cel-Sci Corporation (CELC) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Cel-Sci Corporation (CELC) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Cel-Sci Corporation (CELC) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Cel-Sci Corporation (CELC)?
Creators covering Cel-Sci Corporation (CELC) most frequently also discuss CRDF, SRPT, INTC, AMD, PLTR. See the "Discussed alongside" section above for full asset pages.